Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled to have a specific type of robotic-assisted surgery (using the Da Vinci Xi or SP robotic system) to remove a primary (first-time) tumour in areas such as the base of the tongue, throat, voicebox, or surrounding structures — at certain early-to-moderate stages (Cohort 1)
- People who are scheduled to have the same type of robotic-assisted surgery to remove a tumour that has come back, or a new second tumour, in those same areas of the throat or voicebox — at certain early-to-moderate stages (Cohort 2)
- People who are scheduled to have robotic-assisted surgery to help improve swallowing difficulties, who have previously been treated for head and neck cancer, have been cancer-free for at least 2 years, have normal vocal cord movement confirmed by a specialist camera test, have scored 60 or below on a specific swallowing quality-of-life questionnaire, have scored 5 or above on a swallowing safety assessment, and have already completed at least 20 sessions of speech, swallowing, and voice therapy (Cohort 3)
- People who will need speech, swallowing, and voice rehabilitation after their surgery
- People aged 18 or older at the time of signing the consent form
- People who have signed an informed consent form agreeing to take part
Who may not be able to join:
- People who are unable to give informed consent to participate
- People who are unable to follow the study procedures, which include swallowing assessments, questionnaires, and rehabilitation therapy sessions
- People whose psychological, thinking, family, social, or geographical circumstances may make it difficult to follow the study schedule and complete the required assessments
- People who are unable to remember one analytical and one compensatory exercise at the screening visit
- People who are currently participating in, or have participated within the past 30 days in, another study involving an experimental drug or medical device
- People who have previously been enrolled in this same trial
- People who have a known severe allergic reaction (anaphylaxis) to iodine contrast media (a liquid called Accupaque used in one of the swallowing tests)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +41(0)79 556 08 62
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Swallowing function measured by composite MDADI score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.